These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 36760203)
1. Identification of androgen response-related lncRNAs in prostate cancer. Karthikeyan SK; Xu N; Ferguson Rd JE; Rais-Bahrami S; Qin ZS; Manne U; Netto GJ; S Chandrashekar D; Varambally S Prostate; 2023 May; 83(6):590-601. PubMed ID: 36760203 [TBL] [Abstract][Full Text] [Related]
2. A novel androgen-reduced prostate-specific lncRNA, PSLNR, inhibits prostate-cancer progression in part by regulating the p53-dependent pathway. Wang D; Wan X; Zhang Y; Kong Z; Lu Y; Sun X; Huang Y; Ji C; Li D; Luo J; Gu W; Wang C; Li Y; Xu Y Prostate; 2019 Sep; 79(12):1362-1377. PubMed ID: 31269242 [TBL] [Abstract][Full Text] [Related]
3. PVT1 signals an androgen-dependent transcriptional repression program in prostate cancer cells and a set of the repressed genes predicts high-risk tumors. Videira A; Beckedorff FC; daSilva LF; Verjovski-Almeida S Cell Commun Signal; 2021 Jan; 19(1):5. PubMed ID: 33430890 [TBL] [Abstract][Full Text] [Related]
4. The clock gene BHLHE40 and atypical CCNG2 control androgen-induced cellular senescence as a novel tumor suppressive pathway in prostate cancer. Heidari Horestani M; Atri Roozbahani G; Baniahmad A J Exp Clin Cancer Res; 2024 Jun; 43(1):174. PubMed ID: 38902772 [TBL] [Abstract][Full Text] [Related]
5. The long non-coding RNA PCAL7 promotes prostate cancer by strengthening androgen receptor signaling. Li Z; Teng J; Jia Z; Zhang G; Ai X J Clin Lab Anal; 2021 Feb; 35(2):e23645. PubMed ID: 33219721 [TBL] [Abstract][Full Text] [Related]
6. The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivo. Parolia A; Crea F; Xue H; Wang Y; Mo F; Ramnarine VR; Liu HH; Lin D; Saidy NR; Clermont PL; Cheng H; Collins C; Wang Y; Helgason CD Mol Cancer; 2015 Feb; 14():46. PubMed ID: 25744782 [TBL] [Abstract][Full Text] [Related]
8. Discovery of a novel long noncoding RNA overlapping the LCK gene that regulates prostate cancer cell growth. Ta HQ; Whitworth H; Yin Y; Conaway M; Frierson HF; Campbell MJ; Raj GV; Gioeli D Mol Cancer; 2019 Jun; 18(1):113. PubMed ID: 31253147 [TBL] [Abstract][Full Text] [Related]
9. LINC00675 activates androgen receptor axis signaling pathway to promote castration-resistant prostate cancer progression. Yao M; Shi X; Li Y; Xiao Y; Butler W; Huang Y; Du L; Wu T; Bian X; Shi G; Ye D; Fu G; Wang J; Ren S Cell Death Dis; 2020 Aug; 11(8):638. PubMed ID: 32801300 [TBL] [Abstract][Full Text] [Related]
10. [Roles of long non-coding RNAs in prostate cancer and their action mechanisms]. Li ZF; Xiao N; Yao YW; Yao ZF Zhonghua Nan Ke Xue; 2022 Dec; 28(12):1129-1135. PubMed ID: 37846635 [TBL] [Abstract][Full Text] [Related]
11. Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells. Takayama K; Tsutsumi S; Katayama S; Okayama T; Horie-Inoue K; Ikeda K; Urano T; Kawazu C; Hasegawa A; Ikeo K; Gojyobori T; Ouchi Y; Hayashizaki Y; Aburatani H; Inoue S Oncogene; 2011 Feb; 30(5):619-30. PubMed ID: 20890304 [TBL] [Abstract][Full Text] [Related]
12. Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer. Wan X; Huang W; Yang S; Zhang Y; Pu H; Fu F; Huang Y; Wu H; Li T; Li Y Oncotarget; 2016 Sep; 7(37):60503-60518. PubMed ID: 27556357 [TBL] [Abstract][Full Text] [Related]
13. Modulation of androgen receptor signaling in hormonal therapy-resistant prostate cancer cell lines. Marques RB; Dits NF; Erkens-Schulze S; van Ijcken WF; van Weerden WM; Jenster G PLoS One; 2011; 6(8):e23144. PubMed ID: 21829708 [TBL] [Abstract][Full Text] [Related]
15. Novel lncRNA Lingadahalli S; Jadhao S; Sung YY; Chen M; Hu L; Chen X; Cheung E Mol Cancer Res; 2018 Dec; 16(12):1865-1878. PubMed ID: 30115758 [TBL] [Abstract][Full Text] [Related]
16. Dissecting transcription of the 8q24-MYC locus in prostate cancer recognizes the equilibration between androgen receptor direct and indirect dual-functions. Guo J; Wei Z; Jia T; Wang L; Nama N; Liang J; Liao X; Liu X; Gao Y; Liu X; Wang K; Fu B; Chen SS J Transl Med; 2023 Oct; 21(1):716. PubMed ID: 37828515 [TBL] [Abstract][Full Text] [Related]
17. [Long non-coding RNAs related to androgen receptor function in prostate cancer: Advances in studies]. Wang M; Ying J; Zhang M; Liang CZ Zhonghua Nan Ke Xue; 2019 Aug; 25(8):739-743. PubMed ID: 32227719 [TBL] [Abstract][Full Text] [Related]
18. Role of lncRNAs in prostate cancer development and progression. Weiss M; Plass C; Gerhauser C Biol Chem; 2014 Nov; 395(11):1275-90. PubMed ID: 25153594 [TBL] [Abstract][Full Text] [Related]
19. Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression. Zhang Y; Pitchiaya S; Cieślik M; Niknafs YS; Tien JC; Hosono Y; Iyer MK; Yazdani S; Subramaniam S; Shukla SK; Jiang X; Wang L; Liu TY; Uhl M; Gawronski AR; Qiao Y; Xiao L; Dhanasekaran SM; Juckette KM; Kunju LP; Cao X; Patel U; Batish M; Shukla GC; Paulsen MT; Ljungman M; Jiang H; Mehra R; Backofen R; Sahinalp CS; Freier SM; Watt AT; Guo S; Wei JT; Feng FY; Malik R; Chinnaiyan AM Nat Genet; 2018 Jun; 50(6):814-824. PubMed ID: 29808028 [TBL] [Abstract][Full Text] [Related]
20. LncRNA GAS5 participates in the regulation of dexamethasone on androgen receptor -negative and -positive prostate cancer cell proliferation. Hu J; Deng J; Cao R; Xiong S; Guo J Mol Cell Probes; 2020 Oct; 53():101607. PubMed ID: 32470500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]